Urolithin A and Frailty: Supporting Strength and Physical Function as You Age
Key takeaways
- Frailty is a whole-person syndrome — weakness, slow walking, exhaustion, low activity, and unintended weight loss — not simply low muscle mass.
- Urolithin A has not been studied in people formally diagnosed with frailty; the evidence comes from physical-function and muscle trials in older and middle-aged adults.
- In a randomized trial in adults aged 65–90, a standardized Urolithin A improved muscle measures and lowered energy- and inflammation-related biomarkers, though the trial's primary endpoints were not met. (HUMAN)
- Its proposed mechanism is mitophagy — the cell's recycling of worn-out mitochondria — a pathway closely tied to muscle aging. (PRECLINICAL mechanism)
- It is a once-daily, stimulant-free option meant to complement — never replace — resistance exercise and adequate protein.
What is frailty, and how is it different from sarcopenia?
Frailty is a clinical syndrome of reduced physiological reserve — the body has less of a buffer to draw on when it is stressed by illness, surgery, or even a bad night's sleep. In the widely used frailty phenotype, a person is considered frail when several features cluster together: weak grip strength, slow walking speed, self-reported exhaustion, low physical activity, and unintentional weight loss (a 2024 review of the frailty phenotype).
Sarcopenia — the age-related loss of muscle mass and strength — is one important driver of frailty, but the two are not the same. You can lose muscle without being frail, and frailty involves more systems than muscle alone: metabolism, immune function, and the efficiency with which cells generate energy. Because frailty spans so many systems, interventions that act at the cellular level, rather than on one organ, are of particular scientific interest.
Why do mitochondria matter for strength and stamina as we age?
Mitochondria are the structures inside your cells that convert nutrients and oxygen into ATP, the molecule muscles spend every time they contract. Muscle is especially mitochondria-dense because it has such high energy demands. With age, cells tend to accumulate damaged, inefficient mitochondria, and the housekeeping process that normally clears them out — called mitophagy — becomes less effective. The result is less efficient cellular energy, which researchers believe contributes to the weakness and fatigue that mark declining physical function.
Urolithin A is a postbiotic: your gut bacteria produce it from ellagitannins found in pomegranates, walnuts, and certain berries. In preclinical models, Urolithin A stimulated mitophagy and improved measures of muscle function. In the foundational study, it extended lifespan in the worm C. elegans by roughly 45% and increased running capacity in rodents — effects that disappeared when the animals' mitophagy genes were switched off (Ryu et al., Nature Medicine, 2016). These are PRECLINICAL findings in animals and do not predict outcomes in people.
What does the human research on Urolithin A and physical function show?
Three randomized, placebo-controlled human trials are most relevant to strength and stamina. All used a standardized form of Urolithin A at 500–1,000 mg per day for roughly four months.
In adults aged 65 to 90, four months of 1,000 mg daily did not beat placebo on the two primary endpoints — six-minute walk distance and peak muscle ATP production — and both groups improved over time. However, the Urolithin A group showed greater improvement in hand and leg muscle measures versus placebo, and plasma markers of mitochondrial strain (acylcarnitines), inflammation (C-reactive protein), and cellular stress (ceramides) fell significantly (Liu et al., JAMA Network Open, 2022; ENERGIZE trial registration). (HUMAN)
In untrained, overweight middle-aged adults, four months of 500 or 1,000 mg daily improved isokinetic muscle strength at both doses and moved inflammatory markers (CRP, TNF-α, IL-1β, IFN-γ) in a favorable direction; the 1,000 mg group gained about 33 meters on the six-minute walk test, within the range often considered meaningful. The study's primary exercise-capacity endpoint was not met (Singh et al., Cell Reports Medicine, 2022). (HUMAN)
An earlier first-in-human safety study found Urolithin A well tolerated over four weeks and detected a muscle gene signature consistent with greater mitophagy and mitochondrial biogenesis at 500 and 1,000 mg (Andreux et al., Nature Metabolism, 2019). (HUMAN)
| Study (year) | Population | Dose & duration | Key physical-function findings | Evidence |
|---|---|---|---|---|
| Andreux 2019 | Healthy older adults | 250–1,000 mg, 4 weeks | Well tolerated; muscle mitophagy and biogenesis gene signature | HUMAN |
| Liu 2022 (ENERGIZE) | Adults 65–90 | 1,000 mg, 4 months | Primary endpoints not met; muscle measures improved vs placebo; CRP, acylcarnitines, ceramides fell | HUMAN |
| Singh 2022 | Middle-aged, untrained | 500/1,000 mg, 4 months | Isokinetic strength up at both doses; ~33 m six-minute-walk gain at 1,000 mg | HUMAN |
| Ryu 2016 | Worms & rodents | Varied | ~45% lifespan extension (worms); greater running capacity (rodents) | PRECLINICAL |
What about "inflammaging"?
Frailty travels with chronic, low-grade inflammation, sometimes called inflammaging. In a 2025 randomized trial, a standardized Urolithin A influenced markers associated with aging of the immune system in older adults (D'Amico et al., Nature Aging, 2025), and the consistent drop in C-reactive protein across the muscle trials points in the same direction. (HUMAN) These are biomarker signals — they describe cellular activity, not proof that Urolithin A prevents or reverses frailty.
Can Urolithin A help with frailty specifically?
Here is the honest answer: no supplement, Urolithin A included, has been shown to treat, prevent, or reverse frailty, and no trial has yet enrolled people with a formal frailty diagnosis. What the research supports is narrower and more useful to state plainly. Urolithin A may help support the individual components that underpin physical function — muscle strength and the efficiency of cellular energy production — and it consistently nudges energy- and inflammation-related biomarkers in a favorable direction. Whether that translates into less frailty over years is an open question the current studies were not designed to answer.
How can you use Urolithin A in a strength-supporting routine?
Most people do not produce meaningful amounts of Urolithin A on their own, because it depends on having the right gut bacteria — so-called converter status. A consistent daily dose sidesteps that lottery. The trials above used 500–1,000 mg per day, taken with a meal, for around four months before reassessing. A daily gummy such as SOMA Urolithin A gummies delivers a 1,000 mg dose without capsules or powders to measure.
Supplements work best alongside the two approaches with the strongest evidence for aging muscle: progressive resistance training and adequate dietary protein. Think of Urolithin A as cellular-level support that sits underneath those habits — a complement to lifting and eating well, not a replacement for either.
Frequently asked questions
Does Urolithin A treat frailty?
No. Urolithin A is a dietary supplement, not a treatment for any condition, and it has not been studied in people diagnosed with frailty. The research examines muscle strength, endurance, and cellular-energy biomarkers — factors related to physical function.
How much Urolithin A was used in the studies?
Human trials used 500 to 1,000 mg of a standardized Urolithin A per day. The 1,000 mg dose was the one most often linked to measurable biomarker and muscle changes.
How long before any changes appear?
The trials ran about four months, and some biomarker changes were measurable by two months. Individual responses vary, and consistency matters more than any single dose.
Can I take Urolithin A if I already strength train?
Yes. Urolithin A is intended to complement exercise, not substitute for it. Resistance training and protein remain the foundation for supporting muscle as you age.
Is Urolithin A safe for older adults?
In clinical trials lasting up to four months, a standardized Urolithin A was well tolerated in older adults. As with any supplement, talk with your healthcare provider first — especially if you take medications or manage a health condition.
Support your cellular health, every day
SOMA delivers a high-potency 1,000 mg dose of Urolithin A in one simple daily gummy — no guesswork, no converter-status lottery.
Shop SOMA Urolithin A Gummies →These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.